Hydrogenology
Source-linked study record

Nrf2/HO-1-sulfiredoxin1 pathway involved in nanobubble hydrogen-dissolved water-mediated protective effects by ultrasound-guided early local injection in a rat model of chronic constriction injury-induced neuropathic pain

Yu J, Yin Z, Ma H, Zhang B, Meng C. · Frontiers in molecular neuroscience. 2025;18:1666575.

PreclinicalH₂-rich waterPublished 2025Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Thirty-six rats in a chronic-constriction-injury model of neuropathic pain.

Intervention and dose

Ultrasound-guided local injection of low-concentration nanobubble H₂ water (1,300 ppb) or high-concentration nanobubble H₂ water (2,600 ppb), 5 mL/kg, either once on Day 1 or on Days 1, 3 and 5 after injury. · Low concentration: 1,300 ppb. High concentration: 2,600 ppb. Injection volume: 5 mL/kg.

Duration

One injection on Day 1 or three injections on Days 1, 3 and 5.

Reported result

Article-reported result excerpt (24 words maximum): “After the nanobubble hydrogen-dissolved water was injected, the number of axons increased, and the distribution tended to be neat, which was most evident in…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The full article contains a conflict, commercial-support or supplied-product declaration; consult the source wording.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Controlled preclinical study

Research topic

Musculoskeletal and pain research

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Thirty-six rats in a chronic-constriction-injury model of neuropathic pain.

Sample

36 rats randomized to six groups (n=6 each).

Duration

One injection on Day 1 or three injections on Days 1, 3 and 5.

Intervention

Ultrasound-guided local injection of low-concentration nanobubble H₂ water (1,300 ppb) or high-concentration nanobubble H₂ water (2,600 ppb), 5 mL/kg, either once on Day 1 or on Days 1, 3 and 5 after injury.

Hydrogen form

H₂ dissolved in drinking water plus an injected or infused H₂ intervention — H₂ only unless the full text explicitly reports oxygen co-delivery.

Dose or H₂ specification

Low concentration: 1,300 ppb. High concentration: 2,600 ppb. Injection volume: 5 mL/kg.

Comparator

Sham and untreated chronic-constriction-injury groups, with one-dose and three-dose groups at each H₂ concentration.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

clinical symptoms or functional scores, tumor growth or cancer markers, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury, metabolic laboratory measures

Reported result

Article-reported result excerpt (24 words maximum): “After the nanobubble hydrogen-dissolved water was injected, the number of axons increased, and the distribution tended to be neat, which was most evident in…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The full article contains a conflict, commercial-support or supplied-product declaration; consult the source wording.

Applies directly to

Applies to the reported animal, cell or tissue model, not directly to patients.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 41479560 · DOI: 10.3389/fnmol.2025.1666575

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed/PMC full article; record re-audited and corrected 25 August 2026.

Last reviewed

25 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.